Discontinuation report PHENYLEPHRINE HYDROCHLORIDE INJECTION USP
Report ID | 223140 |
Drug Identification Number | 02504545 |
Brand name | PHENYLEPHRINE HYDROCHLORIDE INJECTION USP |
Common or Proper name | PHENYLEPHRINE HYDROCHLORIDE INJECTION USP |
Company Name | STERIMAX INC |
Market Status | MARKETED |
Active Ingredient(s) | PHENYLEPHRINE HYDROCHLORIDE |
Strength(s) | 10MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
Packaging size | 25 VIALS 1 ML |
ATC code | C01CA |
ATC description | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2024-03-22 |
Actual discontinuation date | 2024-07-30 |
Remaining supply date | 2024-03-22 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | Product will no longer be available upon the depletion of inventory at the wholesalers. |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2024-08-08 | French | Compare |
v3 | 2024-08-08 | English | Compare |
v2 | 2024-03-22 | French | Compare |
v1 | 2024-03-22 | English | Compare |
Showing 1 to 4 of 4